Lifestyle and pregnancy complications in polycystic ovary syndrome: The SCOPE cohort study.


Journal

Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653

Informations de publication

Date de publication:
06 2019
Historique:
received: 21 01 2019
revised: 18 02 2019
accepted: 19 02 2019
pubmed: 26 2 2019
medline: 15 8 2020
entrez: 26 2 2019
Statut: ppublish

Résumé

To investigate the risk of pregnancy complications in women with and without polycystic ovary syndrome after consideration of lifestyle factors. Prospective cohort. Participants (n = 5628) were apparently healthy nulliparous women with singleton pregnancies from the Screening for Pregnancy Endpoints study in New Zealand, Australia, United Kingdom and Ireland. Multivariable regression models were performed assessing the association of self-reported polycystic ovary syndrome status with pregnancy complications with consideration of lifestyle factors at the 15th week of gestation. Women with polycystic ovary syndrome (n = 354) were older, had a higher socio-economic index and body mass index and were less likely to consume alcohol and smoke but more likely to do vigorous exercise and take multivitamins. In univariable analysis, polycystic ovary syndrome was associated with increased risk of gestational diabetes (OR: 2.2, 95% CI: 1.2, 4.0). In multivariable models, polycystic ovary syndrome was only significantly associated with decreased risk of large for gestational age (OR: 0.62, 95% CI: 0.40, 0.98) with a population attributable risk of 0.22%. None of the other outcomes were attributable to polycystic ovary syndrome status. Polycystic ovary syndrome is associated with a lower risk of large for gestational age infants. In this low-risk population, the risk of pregnancy complications was not increased in women with polycystic ovary syndrome who were following a healthy lifestyle. Further studies are warranted assessing the contribution of lifestyle factors to the risk of pregnancy complications in higher risk groups of women with and without polycystic ovary syndrome.

Identifiants

pubmed: 30801750
doi: 10.1111/cen.13954
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

814-821

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : GT084
Pays : United Kingdom

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Mahnaz Bahri Khomami (M)

Monash Center for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Lisa J Moran (LJ)

Monash Center for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.

Louise Kenny (L)

Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Jessica A Grieger (JA)

Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
Adelaide Medical School, North Terrace, University of Adelaide, Adelaide, South Australia, Australia.

Jenny Myers (J)

The Maternal and Fetal Health Research Center, University of Manchester, Manchester, UK.

Lucilla Poston (L)

Department of Women and Children's Health, King's College, London, UK.

Lesley McCowan (L)

Department of Obstetrics and Gynecology, University of Auckland, Auckland, New Zealand.

James Walker (J)

Department of Obstetrics and Gynecology, University of Leeds, Leeds, UK.

Gustaaf Dekker (G)

Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
Adelaide Medical School, North Terrace, University of Adelaide, Adelaide, South Australia, Australia.
Women and Children's Division, Lyell McEwin Hospital, University of Adelaide, Adelaide, South Australia, Australia.

Robert Norman (R)

Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
Fertility SA, Adelaide, South Australia, Australia.

Claire T Roberts (CT)

Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
Adelaide Medical School, North Terrace, University of Adelaide, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH